Tramadol Hydrochloride
Product Images NDC 50090-3000

4 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 50090-3000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl500903000)

Label Image (Lbl500903000)
Tramadol Hydrochloride 50 mg tablet bottle label from A-S Medication Solutions. The label includes the product number 9132-0 and NDC 50090-3000-0, with instructions to store tablets at 59 to 77 degrees Fahrenheit and a total of 33 tablets in the bottle. The label also features a barcode and a QR code.*
FDA Label Image

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)
Chemical structure diagram showing the molecular structure of Tramadol Hydrochloride. The diagram highlights key functional groups and the hydrochloride component indicated by ".HCl".*
FDA Label Image

Figure 1 (Tramadol HCl Tablets Usp 2)

Figure 1 (Tramadol HCl Tablets Usp 2)
A pharmacokinetic curve depicting concentration (ng/mL) versus time (hours) for Tramadol and its metabolite M1 after single and multiple dosing. The graph includes four curves: Tramadol multiple dose, Tramadol single dose, M1 multiple dose, and M1 single dose, showing concentration changes over a 48-hour period.*
FDA Label Image

Fig 2 (Tramadol HCl Tablets Usp 3)

Fig 2 (Tramadol HCl Tablets Usp 3)
A line graph titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting' showing percent discontinuing on the y-axis and days in double-blind on the x-axis. It compares two groups: '10 Days to 200 mg/day' (solid line) and '16 Days to 200 mg/day' (dashed line), with the former showing a higher rate of discontinuation over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.